Polaryx Therapeutics Inc (PLYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -8,985 | -30,356 |
| Accounts payable and accrued liabilities | 398 | -401 |
| Other Working Capital | 316 | -621 |
| Other Operating Activity | 4,327 | 28,805 |
| Operating Cash Flow | $-3,944 | $-2,573 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | N/A | 65 |
| Common Stock Issued | 4,493 | 7,320 |
| Common Stock Repurchased | -27 | N/A |
| Other Financing Activity | 0 | -193 |
| Financing Cash Flow | $4,466 | $7,192 |
| Beginning Cash Position | 4,621 | 2 |
| End Cash Position | 5,143 | 4,621 |
| Net Cash Flow | $522 | $4,619 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,944 | -2,573 |
| Free Cash Flow | -3,944 | -2,573 |